SunTrust Robinson Humphrey Downgrades Achaogen (AKAO) to Hold

Go back to SunTrust Robinson Humphrey Downgrades Achaogen (AKAO) to Hold

H.C. Wainwright Downgrades Achaogen (AKAO) to Neutral

November 12, 2018 7:24 AM EST

H.C. Wainwright analyst Ed Arce downgraded Achaogen (NASDAQ: AKAO) from Buy to Neutral with a price target of $3.00.

Arce commented, "Last Monday, November 5, Achaogen announced that it has begun a review of strategic alternatives, with the assistance of a financial advisor, to maximize shareholder value, including but not limited to the potential sale or merger of the company or... More

Wedbush Downgrades Achaogen (AKAO) to Neutral

November 12, 2018 6:31 AM EST

Wedbush analyst Robert Driscoll downgraded Achaogen (NASDAQ: AKAO) from Outperform to Neutral with a price target of $3.00 (from $17.00).

For an analyst ratings summary and ratings history on Achaogen click here. For more ratings news on Achaogen click here.

Shares of Achaogen closed at $2.25 yesterday.

... More

Mizuho Securities Downgrades Achaogen (AKAO) to Neutral

November 9, 2018 5:33 AM EST

Mizuho Securities analyst Difei Yang downgraded Achaogen (NASDAQ: AKAO) from Buy to Neutral with a price target of $3.00 (from $8.00).

The analyst comments "Achaogen faces significant liquidity issues with a cash runway into the middle of 1Q19 per management on yesterday morning's 3Q18... More

Stifel Downgrades Achaogen (AKAO) to Hold

November 9, 2018 5:03 AM EST

Stifel analyst Stephen Willey downgraded Achaogen (NASDAQ: AKAO) from Buy to Hold with a price target of $3.00 (from $14.00).

The analyst cites skepticism on value-creating strategic options for stepping to the sidelines.

For an analyst ratings summary and ratings history on... More

Gabelli Downgrades Achaogen (AKAO) to Hold

November 9, 2018 4:01 AM EST

Gabelli analyst Kevin Kedra downgraded Achaogen (NASDAQ: AKAO) from Buy to Hold.

The analyst cites the tough environment the company faces after Q3 for stepping to the sidelines.

For an analyst ratings summary and ratings history on Achaogen... More

Cowen Downgrades Achaogen (AKAO) to Market Perform

November 9, 2018 3:35 AM EST

Cowen analyst Chris Shibutani downgraded Achaogen (NASDAQ: AKAO) from Outperform to Market Perform.

The analyst comments "Even acknowledging share underperformance YTD, AKAOs 3Q18 update including a much weaker than hoped for Zemdri launch, and restructuring decisions which have devolved from prudent to now... More